Based in Berlin, Novonesis Berlin GmbH specialises in the research and development of probiotics for the food, pharmaceutical, hygiene, and animal and human nutrition industries.
Novonesis provides probiotics with proven beneficial effects on gastrointestinal health.
Founded in 2001, the company relies on its own strain collection to develop and market unique, effective, and patentable products.
It holds a diverse collection of yeasts and lactobacilli, with some strains dating back to the 1920s.
Novonesis Berlin GmbH, formerly known as Organobalance, has been part of the Novozymes Group — which became Novonesis in 2024 — since September 2016. Novonesis is a global leader in biotechnology and a specialist in enzymes.
For more information, feel free to visit their website: https://www.novonesis.com
